Quantel Medical receives FDA approval for next-generation Compact Touch ophthalmic ultrasound platform

Quantel Medical receives FDA approval for next-generation Compact Touch ophthalmic ultrasound platform

Quantel Medical receives FDA approval for next-generation Compact Touch ophthalmic ultrasound platform

Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on March 02, 2018 for the Next-Generation Compact Touch Ophthalmic Ultrasound Platform.

Since the first generation of Compact Touch was launched in 2008, more than 3,300 units have been sold worldwide. This best-selling Quantel Medical ultrasound product has been prized for its high image quality, intuitive software, compact design and versatility.

Improvements in the new generation of Compact Touch include a new 15 MHz B probe to increase the quality of the B-scan imaging essential to vitreo-retinal specialists. Interactivity is enhanced with DICOM compatibility, WiFi and Bluetooth connectivity and HDMI video output. The sleek, modern design now utilizes a new generation touch screen interface, and the device is fanless and silent as a tablet. User-friendly design and software enhancements improve workflow.

The new generation 15 MHz B probe of the Compact Touch offers a resolution increased by 30%, which enables me to better differentiate thin vitreous membranes and retinal detachments. It also allows me to visualize tumors inferior to 2mm. In addition, the system automatically measures the axial length from the B-mode image, which is advantageous when I am evaluating patients who have long myopic eyes, such as patients with staphylomas.

Dr. Bievelez – Paufique ophthalmologic center, Lyon, France

We are excited to share with American ophthalmic specialists and their patients the clinical advantages of the new generation of Compact Touch, which enhanced image quality will aid diagnosis. I think physicians also will consider this state-of-the-art technology very practical because these capabilities come in a sleek, portable, well- designed and highly interactive package.

Jean‐Marc Gendre, CEO of Quantel Medical

At the upcoming ASCRS Congress, to be held in Washington April 13-17, the attendees will have the possibility to get a full review of the new generation of the Compact Touch ultrasound platform with its new B-mode probe and get additional information in exhibit booth #850.

You are currently browsing on Lumibird Medical’s corporate website. If you want to browse another content, please follow one of this link.
The information collected through this form is recorded and transmitted to the relevant LUMIBIRD MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to LUMIBIRD MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@lumibirdmedical.com.
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.